Tuesday, September 25, 2018
Korean Bio Startup Comes in Second in Innovation Challenge
13 Firms Meet Investors at RESI
Korean Bio Startup Comes in Second in Innovation Challenge
  • By Choi Mun-hee
  • June 19, 2018, 14:39
Share articles

 

The Redefining Early Stage Investment (RESI), one of the world's largest partnering conferences in the bio start-up sector, was held in Boston, the US, on June 4 (local time).
The Redefining Early Stage Investment (RESI), one of the world's largest partnering conferences in the bio start-up sector, was held in Boston, the US, on June 4 (local time).
wave talk
Kim Yeong-deok (left), a co-founder of The Wave Talk, and Lee Seung-ah, a partner of the company, stand next to a board introducing the Korean bio start-up. The Wave Talk picked up the second prize in the Innovation Challenge presentation session of the RESI conferece, which is a global gathering of investors and CEOs of life science start-ups. 

The Korea Biotechnology Industry Organization participated in the Redefining Early Stage Investments (RESI) conference held in Boston, the US, on June 4 (local time) to introduce promising Korean bio start-up companies to early stage investors from around the globe.

The Wave Talk, one of the 13 Korean bio companies, picked up the second prize in the Innovation Challenge presentation session.

In particular, 11 of the 13 Korean bio start-ups made a presentation in the Innovation Challenge, where a total of 30 companies from around the world were given a chance to introduce themselves to investors.

The Wave Talk attracted the attention of many investors by introducing its technology for real-time detection of bacteria. Its laser-based sensor is many times more accurate than conventional laser and is able to detect even low concentration of bacteria in real time.

Apart from The Wave Talk, Korean companies that participated in the RESI conference are Nosquest, Deep Medi, RadianQbio, Bally's, CellSafe, L Base, MDimune, Optolane, ImmuneMed, Infit & Company, Quratis and Panagene.

RESI is one of the world's largest partnering conferences in the bio start-up sector. It is dedicated to matching early stage investors with fundraising CEOs of life science companies. In addition to Innovation Challenge, RESI features one-on-one partnering and investment-related professional sessions.

Participating Korean companies held meetings with multinational pharmaceutical companies such as Sanofi and Roche and venture capital companies through one-to-one partnering. They received good responses from investors by holding IR events.

In the meantime, Korean bio start-ups could take part in the RESI conference under the K-Startup Meetup 2018 Boston program, which was jointly organized by the Korea Biotechnology Industry Organization, KOTRA, the COMPA, the Korea Institute of Marine Science & Technology Promotion. The Korea Biotechnology Industry Organization held IR education sessions three times to help the participating startups prepare a presentation.